(Q41450497)

30 September 2017

1 reference

title

Medical approaches in the management of prostatic disease (English)

1 reference

30 September 2017

Droller MJ

1

1 reference

30 September 2017

1 April 1997

1 reference

British Journal of Urology

30 September 2017

1 reference

30 September 2017

79 Suppl 2

1 reference

30 September 2017

42-52

1 reference

30 September 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Androgen- and Estrogen-Receptor Content in Spontaneous and Experimentally Induced Canine Prostatic Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Androgen receptor localization in different cell types of the adult rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Differential effects of growth factor antagonists on neoplastic and normal prostatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Cadherin cell adhesion receptors as a morphogenetic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

The cellular basis of site-specific tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

Androgen receptor gene mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB16920.X

10.1111/J.1464-410X.1997.TB16920.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9126069